Showing results (31-40 of 1,250) with videos related to
Sort By:
Pageof 125
Neurological Research and Practice|July 10, 2022
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from GermanyRaphael Scherbaum, Dirk Bartig, Daniel Richter, et al.Cells|February 3, 2019
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's DiseaseMaria Angela Samis Zella, Judith Metzdorf, Friederike Ostendorf, et al.Neurological Research and Practice|July 28, 2025
User groups of inpatient multidisciplinary therapies for Parkinson's disease in Germany: a bicenter prospective observational studyVera Tschentscher, Judith Oppermann, Julius Welzel, et al.Expert Review of Neurotherapeutics|October 4, 2017
Valbenazine for the treatment of tardive dyskinesiaThomas MüllerTranslational Neurodegeneration|December 6, 2012
Drug therapy in patients with Parkinson's diseaseThomas MüllerExpert Review of Neurotherapeutics|May 29, 2008
Role of homocysteine in the treatment of Parkinson's diseaseThomas MüllerExpert Opinion on Drug Metabolism & Toxicology|May 25, 2017
Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's diseaseThomas MüllerNeurodegenerative Disease Management|September 8, 2016
Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspectiveThomas MüllerBerichte Zur Wissenschaftsgeschichte|December 13, 2006
[Medical expertise--the Zionist vision: medicine and physicians among the immigrants to Palestine/Israel]Thomas MüllerPageof 125